0001574774-18-000048.txt : 20180725 0001574774-18-000048.hdr.sgml : 20180725 20180725185306 ACCESSION NUMBER: 0001574774-18-000048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180723 FILED AS OF DATE: 20180725 DATE AS OF CHANGE: 20180725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GORMAN KIRK E CENTRAL INDEX KEY: 0001181032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55039 FILM NUMBER: 18969652 MAIL ADDRESS: STREET 1: 367 SOUTH GULPH ROAD CITY: KING PRUSSIA STATE: PA ZIP: 19406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTELEMETRY, INC. CENTRAL INDEX KEY: 0001574774 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 462568498 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 CEDAR HOLLOW ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-729-7000 MAIL ADDRESS: STREET 1: 1000 CEDAR HOLLOW ROAD CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: BioTelemetry, Inc. DATE OF NAME CHANGE: 20130418 4 1 wf-form4_153255917122191.xml FORM 4 X0306 4 2018-07-23 0 0001574774 BIOTELEMETRY, INC. BEAT 0001181032 GORMAN KIRK E 1000 CEDAR HOLLOW RD. SUITE 102 MALVERN PA 19355 1 0 0 0 Common Stock 2018-07-23 4 M 0 7500 30.98 A 180815 D Common Stock 2018-07-23 4 S 0 7500 50.74 D 173315 D Stock Options (Right to Buy) 30.98 2018-07-23 4 M 0 7500 0 D 2018-08-18 Common Stock 7500.0 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $50.20 to $51.00, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The options were fully exercisable on the third anniversary of the date of grant. /s/ Peter F. Ferola, Attorney-in-Fact 2018-07-25